112 related articles for article (PubMed ID: 8621857)
1. The effects of prednisolone on the cutaneous tuberculin response in patients with corticosteroid-resistant bronchial asthma.
Sousa AR; Lane SJ; Atkinson BA; Poston RN; Lee TH
J Allergy Clin Immunol; 1996 Feb; 97(2):698-706. PubMed ID: 8621857
[TBL] [Abstract][Full Text] [Related]
2. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosyphorylation of JUN N-terminal kinase and failure of prednisolone to inhibit JUN N-terminal kinase phosphorylation.
Sousa AR; Lane SJ; Soh C; Lee TH
J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):565-74. PubMed ID: 10482829
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma.
Lock SH; Kay AB; Barnes NC
Am J Respir Crit Care Med; 1996 Feb; 153(2):509-14. PubMed ID: 8564089
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil cationic protein in serum of corticosteroid-sensitive and resistant bronchial asthma.
Patkowski J; Wytrychowski K; Medrala W
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):195-200. PubMed ID: 9597087
[TBL] [Abstract][Full Text] [Related]
5. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.
Bentley AM; Hamid Q; Robinson DS; Schotman E; Meng Q; Assoufi B; Kay AB; Durham SR
Am J Respir Crit Care Med; 1996 Feb; 153(2):551-6. PubMed ID: 8564096
[TBL] [Abstract][Full Text] [Related]
6. Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation.
Sousa AR; Marshall RP; Warnock LC; Bolton S; Hastie A; Symon F; Hargadon B; Marshall H; Richardson M; Brightling CE; Haldar P; Milone R; Chalk P; Williamson R; Panettieri R; Knowles R; Bleecker ER; Wardlaw AJ
Clin Exp Allergy; 2017 Jul; 47(7):890-899. PubMed ID: 28493293
[TBL] [Abstract][Full Text] [Related]
7. Immune response to influenza vaccination in children and adults with asthma: effect of corticosteroid therapy.
Hanania NA; Sockrider M; Castro M; Holbrook JT; Tonascia J; Wise R; Atmar RL;
J Allergy Clin Immunol; 2004 Apr; 113(4):717-24. PubMed ID: 15100679
[TBL] [Abstract][Full Text] [Related]
8. Reaction to intradermally applied phytohaemagglutinin in asthma patients in relation to corticosteroid therapy.
Kruszewski J; Płusa T; Szczylik C; Wiktor-Jedrzejczak W
Allergy; 1983 Apr; 38(3):201-5. PubMed ID: 6846748
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression.
Robinson D; Hamid Q; Ying S; Bentley A; Assoufi B; Durham S; Kay AB
Am Rev Respir Dis; 1993 Aug; 148(2):401-6. PubMed ID: 8342904
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid-resistant chronic asthma and monocyte complement receptors.
Kay AB; Diaz P; Carmicheal J; Grant IW
Clin Exp Immunol; 1981 Jun; 44(3):576-80. PubMed ID: 7326867
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma.
Meijer RJ; Kerstjens HA; Arends LR; Kauffman HF; Koëter GH; Postma DS
Thorax; 1999 Oct; 54(10):894-9. PubMed ID: 10491451
[TBL] [Abstract][Full Text] [Related]
12. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation.
Djukanović R; Homeyard S; Gratziou C; Madden J; Walls A; Montefort S; Peroni D; Polosa R; Holgate S; Howarth P
Am J Respir Crit Care Med; 1997 Mar; 155(3):826-32. PubMed ID: 9117012
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid resistance in chronic asthma.
Carmichael J; Paterson IC; Diaz P; Crompton GK; Kay AB; Grant IW
Br Med J (Clin Res Ed); 1981 May; 282(6274):1419-22. PubMed ID: 6784848
[TBL] [Abstract][Full Text] [Related]
14. Nifedipine in corticosteroid-dependent asthma: preliminary study.
al-Waili NS
Clin Exp Pharmacol Physiol; 1989 Sep; 16(9):715-8. PubMed ID: 2680186
[TBL] [Abstract][Full Text] [Related]
15. Effects of prednisolone on bone turnover in patients with corticosteroid resistant asthma.
Lane SJ; Vaja S; Swaminathan R; Lee TH
Clin Exp Allergy; 1996 Oct; 26(10):1197-201. PubMed ID: 8911707
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial.
Bernstein IL; Bernstein DI; Dubb JW; Faiferman I; Wallin B
J Allergy Clin Immunol; 1996 Aug; 98(2):317-24. PubMed ID: 8757209
[TBL] [Abstract][Full Text] [Related]
17. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial.
Harrison TW; Oborne J; Newton S; Tattersfield AE
Lancet; 2004 Jan; 363(9405):271-5. PubMed ID: 14751699
[TBL] [Abstract][Full Text] [Related]
18. Increased serum VDBP as a risk predictor for steroid resistance in asthma patients.
Jiang H; Chi X; Zhang X; Wang J
Respir Med; 2016 May; 114():111-6. PubMed ID: 27109820
[TBL] [Abstract][Full Text] [Related]
19. Does nedocromil sodium have a steroid sparing effect in adult asthmatic patients requiring maintenance oral corticosteroids?
Goldin JG; Bateman ED
Thorax; 1988 Dec; 43(12):982-6. PubMed ID: 2853457
[TBL] [Abstract][Full Text] [Related]
20. Effects of short-term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma - a randomized controlled trial.
Berthon BS; Gibson PG; McElduff P; MacDonald-Wicks LK; Wood LG
Clin Exp Allergy; 2015 May; 45(5):908-919. PubMed ID: 25640664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
